Hyderabad-based Bharat Biotech on Wednesday released the results of phase 1 trials of its coronavirus (Covid-19) vaccine ‘Covaxin’, which produced a robust immune response against the disease and showed that most of the adverse events were mild and resolved. The vaccine is stored between 2 and 8 degrees Celsius and …
Read More »Covaxin Phase 1 Trial Result Shows Strong Immune Response and Mild Adverse Events
